Inspire Medical Systems Analysts Raise Their Forecasts Following Strong Q2 Results
INSPI beats expectations, raises FY26 guidance. Analysts raise price targets to $59 & $60. Stock jumps 14.6% in pre-market trading. #INSP
Inspire Medical did better than people expected in its latest quarter, so experts think the company will do well this year—that's why they're saying the stock might be worth more money. When analysts become more confident about a company, it usually means they see something good happening, so paying attention to their reasons helps you understand what's working.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.